Trade Brains

NOVEMBER 24, 2023

In FY2023, they added over 250+ clients in B2B and B2B2C segments and over 850+ clients across various industries, with a retention ratio of more than 90%. Revenues and profits are increasing at the growth stage, and the high P/E commanding the current valuations will be justified by the company’s growth rate.

Planning 69

Planning B2C B2B Pharmaceutical 69

Steve Sanduski

JANUARY 20, 2023

I talked to Michael about the opportunity in private equity and how he and his team analyze and invest in the B2B software market. Tech company valuations were cratering, but interest in tech was still high thanks to the exploding popularity of the internet. . “Making it the best it can possibly be.”

B2B 52

B2B Investments Investing Media 52

Trade Brains

OCTOBER 9, 2022

Services provided by the company: Through its Tracxn platform, the business makes private corporate data available to its clients for a variety of purposes, including deal sourcing, target identification for M&A transactions, deal diligence, analysis, and tracking new market and industry trends. Source: DRHP of the company).

B2B 52

B2B Numbers Marketing Marketing 52

The Big Picture

MARCH 25, 2025

As you note, when we spun out, we kept all of our Bear Stearns accounts, continued to work with all their private client service people over there. Valuations tended to crash and burn very, very cheap valuations tended to do well. But the original thing Barry, was we wanted to serve you our clients better and faster.

Management 147

Management Numbers Investments Investing 147

The Big Picture

NOVEMBER 4, 2024

00:06:39 [Speaker Changed] So clients, the LPs who come to Oak, were they just giving them cash to be allocated across all these different sectors? So pharma is a client, employers, payer employer market as a client and payers our clients beyond our customers of our companies, beyond just hospital systems.

Healthcare 130

Healthcare Medical Investments Investing 130